Functioning pulmonary metastases of thyroid cancer: Does radioiodine influence the prognosis?

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 7, 2003, Pages 974-981

  Hindié, Elif ^a   Mellière, Didier ^b   Lange, Françoise ^b   Hallaj, Iyad ^c   De Labriolle Vaylet, Claire ^a   Jeanguillaume, Christian ^d   Lange, Jacques ^e   Perlemuter, Léon ^b   Askienazy, Serge ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e Clinique du Sud   (France)

Author keywords

Functioning metastases; Iodine 131; Pulmonary metastases; Radionuclide scanning; Radionuclide therapy; Thyroid cancer

Indexed keywords

IODINE 131; RADIOACTIVE IODINE; THYROGLOBULIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; LUNG SCINTISCANNING; LUNG SURGERY; MALE; OUTCOMES RESEARCH; PROGNOSIS; RADIATION DOSE; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; THORAX RADIOGRAPHY; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FRANCE; HUMANS; IODINE RADIOISOTOPES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SURVIVAL RATE; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 0043194337     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1174-5     Document Type: Article

References (35)

1. Kitamura Y, Shimizu K, Nagahama M, et al. Immediate causes of death in thyroid carcinoma: clinicopathological analysis of 161 fatal cases. J Clin Endocrinol Metab 1999; 84:4043-4049.
2. Massin J-P, Savoie J-C, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma: study of 58 cases with implications for the primary tumor treatment. Cancer 1984; 53:982-992.
3. Samaan NA, Scultz P, Haynie TP, Ordonez NG. Pulmonary metastasis of differentiated thyroid carcinoma: treatment results in 101 patients. J Clin Endocrinol Metab 1985; 60:376-380.
4. Casara D, Rubello D, Saladini G, Masarotto G, Favero A, Girelli M, Busnardo B. Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993; 34:1626-1631.
5. Ruegemer JJ, Hay ID, Bergstralh EJ, Ryan JJ, Offord KP, Gorman CA. Distant metastases in differentiated throid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988; 67:501-508.
6. Hoie J, Stenwig AE, Kullman G, Lindegaard M. Distant metastases in papillary thyroid cancer: a review of 91 patients. Cancer 1988; 61:1-6.
7. Shaha AR, Shah JP, Loree TR. Patterns of nodal and distant metastasis based on histologic varieties in differentiated thyroid carcinoma of the thyroid. Am J Surg 1996; 172:692-694.
8. Seidlin SM, Marinelli LD, Oshry E. Radioactive iodine therapy: effect on functioning metastses of adenocarcinoma of the thyroid. JAMA 1946; 132:838-847.
9. Brown AP, Greening WP, McCready VR, Shaw HJ, Harmer CL. Radioiodine treatment of metastatic thyroid carcinoma: the Royal Marsden Hospital experience. Br J Radiol 1984; 57:323-327.
10. Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic thyroid carcinoma treated with radioiodine. World J Surg 1994; 18:600-604.
11. Schlumberger M, Challeton C, De Vathaire F, et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med 1996;37:598-605.
12. Varma VM, Beierwaltes WH, Nofal MM, Nishiyama RH, Copp JE. Treatment of thyroid cancer: death rates after surgery and after surgery followed by sodium iodide I-131. JAMA 1970; 214:1437-1442.
13. Samaan NA, Schultz P, Hickey RC, Goepfert H, Haynie TP, Johnston DA, Ordonez NG. The results of various modalities of treatment of well differentiated thyroid carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab 1992; 75:714-720.
14. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994; 97:418-428.
15. Haugen BR, Pacini F, Reiners C, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999; 84:3877-3885
16. Turner JE, Weier GJ Jr. Pulmonary metastases from thyroid carcinoma detectable only by 131-I scan. J Nucl Med 1972; 13:852.
17. Wartofsky L, Sherman SI, Gopal J, Schlumberger M, Hay ID. Therapeutic controversy: the use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998; 83:4195-4203.
18. Dinneen SF, Valimaki MJ, Bergstralh EJ, Goellner JR, Gorman CA, Hay ID. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995; 80:2041-2045.
19. Mellière D, Berrahal D, Hindié E, Becquemin JP, Lange F. Differentiated thyroid carcinoma: long term results of a management protocol based on simple prognostic criteria. Presse Med 1997; 26:1276-1283.
20. Marcocci C, Pacini F, Elisi R, et al. Clinical and biological behavior of bone metastases from differentiated thyroid carcinoma. Surgery 1989; 106:960-966.
21. Bernier MO, Leenhardt L, Hoang C, et al. Survival and therapeutic modalities in patients with bone metastases of differentiated thyroid carcinomas. J Clin Endocrinol Metab 2001; 86:1568-1573.
22. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med 1988; 29:1790-1794.
23. Filesi M, Signore A, Ventroni G, Melacrinis FF, Ronga G. Role of initial iodine-131 wholebody scan and serum thyroglobulin in differentiated thyroid carcinoma metastases. J Nucl Med 1998; 39:1542-1546.
24. Vassilopoulou-Sellin R, Libshitz HI, Haynie TP. Papillary thyroid cancer with pulmonary metastases beginning in childhood. Clinical course over three decades. Med Pediatr Oncol 1995; 24:119-122.
25. Samuel AM, Rajashekharrao B, Shah DH. Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer. J Nucl Med 1998; 39:1531-1536.
26. Shen DNH, Kloos RT, Mazzaferri EL, Jhiang SM. Sodium iodide symporter in health and disease. Thyroid 2001; 11:415-425.
27. Hindié E, Leenhardt L, Vitaux F, et al. Non-medical exposure to radioiodines and thyroid cancer. Eur J Nucl Med Mol Imaging 2002; 29 Suppl 2:S497-S512.
28. Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59:45-51.
29. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995; 36:21-27.
30. DeVathaire F, Schlumberger M, Delisle MJ, et al. Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer 1997; 75:734-739.
31. Sisson JC, Jamadar DA, Kazerooni EA, Giordano TJ, Carey JE, Spaulding SA. Treatment of micronodular lung metastases of papillary thyroid cancer: are the tumors too small for effective irradiation from radioiodine? Thyroid 1998; 8:215-221.
32. 131I scanning results after therapy. J Nucl Med 2001; 42:1464-1469.
33. 18F-fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med Mol Imaging 2002; 29:641-647.
34. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379:458-460.
35. Simon D, Korber C, Krausch M, et al. Clinical impact of retinoids in redifferentiation therapy of advanced thyroid cancer: final results of a pilot study. Eur J Nucl Med Mol Imaging 2002; 29:775-782.